Acalabrutinib — a new option in CLL
Crossref DOI link: https://doi.org/10.1038/s41571-020-0381-3
Published Online: 2020-05-01
Published Print: 2020-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2020-05-01
Version of Record valid from 2020-05-01
Article History
First Online: 1 May 2020
Free to read: This content has been made available to all.